As SLC37A2 negatively regulates macrophage glycolysis and inflammation, we speculate that increased SLC37A2 expression in obesity might serve as a compensatory mechanism to lower intracellular glucose and attenuate obesity-induced inflammation. This evidence concerns the gene SLC37A2 and Obesity.